Knowledge (XXG)

Phosphodiesterase inhibitor

Source 📝

328: 31: 362:, a neuroprotective and bronchodilator drug used mainly in the treatment of asthma and stroke. It inhibits PDE4 to the greatest extent, but also shows significant inhibition of other PDE subtypes, and so acts as a selective PDE4 inhibitor or a non-selective phosphodiesterase inhibitor, depending on the dose. 1020: 1577:
Bobon D, Breulet M, Gerard-Vandenhove MA, Guiot-Goffioul F, Plomteux G, Sastre-y-Hernandez M, Schratzer M, Troisfontaines B, von Frenckell R, Wachtel H (1988). "Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine
467:
reported that researchers at their institution had discovered a link between elevated levels of PDE4 (and therefore decreased levels of cAMP) in sleep deprived mice. Treatment with a PDE4 inhibitor raised the deficient cAMP levels and restored some functionality to hippocampus-based memory functions.
73:
The different forms or subtypes of phosphodiesterase were initially isolated from rat brains in the early 1970s and were soon afterward shown to be selectively inhibited in the brain and in other tissues by a variety of drugs. The potential for selective phosphodiesterase inhibitors as therapeutic
2030:
Inhibitory Mechanism of Papaverine on Carbachol-Induced Contraction in Bovine Trachea; Takeharu Kaneda1,*, Yukako Takeuchi1, Hirozumi Matsui1, Kazumasa Shimizu1, Norimoto Urakawa1,and Shinjiro Nakajyo, Division of Veterinary Pharmacology, Nippon Veterinary and Animal Science University;
1806:
Guerreiro, Serge; Toulorge, Damien; Hirsch, Etienne; Marien, Marc; Sokoloff, Pierre; Michel, Patrick P. (October 2008). "Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels".
1770:
Redondo, M.; Zarruk, JG.; Ceballos, P.; Pérez, DI.; Pérez, C.; Perez-Castillo, A.; Moro, MA.; Brea, J.; et al. (Jan 2012). "Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model".
2078:
Effects of phosphodiesterase 10 inhibition on striatal cyclic AMP and peripheral physiology in rats; An Torremans, Abdellah Ahnaou, An Van Hemelrijck, Roel Straetemans, Helena Geys, Greet Vanhoof, Theo F. Meert, and Wilhelmus H. Drinkenburg;
1511:
Yu MC, Chen JH, Lai CY, Han CY, Ko WC (2009). "Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1–5, displaced -rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia".
65:(cGMP) by the respective PDE subtype(s). The ubiquitous presence of this enzyme means that non-specific inhibitors have a wide range of actions, the actions in the heart, and lungs being some of the first to find a therapeutic use. 1135:
Shamim MT, Ukena D, Padgett WL, Daly JW (June 1989). "Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions".
993: 1875:
Orrú, Marco; Guitart, Xavier; Karcz-Kubicha, Marzena; Solinas, Marcello; Justinova, Zuzana; Barodia, Sandeep Kumar; Zanoveli, Janaina; Cortes, Antoni; Lluis, Carme; Casado, Vicent; Moeller, F. Gerard (April 2013).
1547: 560:(84% in humans), is another cGMP-specific phosphodiesterase inhibitor which inhibits PDE9, a cGMP preferring phosphodiesterase. PDE9 is expressed as high as PDE5 in the corpus cavernosum. 1000:, Sunshine A, Laska EM, Siegel CE, "ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME", granted 1989-03-22, assigned to RICHARDSON-VICKS, INC. 638:
Uzunov P.; Weiss B. (1972). "Separation of multiple molecular forms of cyclic adenosine 3',5'-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis".
2144: 133:, a drug that has the potential to enhance circulation and may have applicability in treatment of diabetes, fibrotic disorders, peripheral nerve damage, and microvascular injuries 432:
PDE4 is the major cAMP-metabolizing enzyme found in inflammatory and immune cells. PDE4 inhibitors have proven potential as anti-inflammatory drugs, especially in inflammatory
990: 1713:
Vecsey CG, Baillie GS, Jaganath D, Havekes R, Daniels A, Wimmer M, Huang T, Brown KM, Li XY, Descalzi G, Kim SS, Chen T, Shang YZ, Zhuo M, Houslay MD, Abel T (2009).
1386:
Baraldi PG, Tabrizi MA, Gessi S, Borea PA (January 2008). "Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility".
1555: 1098:"Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors" 3010: 2169: 1034:
Daly JW, Padgett WL, Shamim MT (July 1986). "Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors".
2137: 2112: 858:
Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U (February 1999). "Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages".
1621:
Maxwell CR, Kanes SJ, Abel T, Siegel SJ (2004). "Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications".
1343:
González MP, Terán C, Teijeira M (May 2008). "Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?".
2217: 1935:"Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide–cyclic GMP pathway in mice" 3433: 2130: 441: 1423:"Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case report" 87: 811:"Insights into the Regulation of TNF-α Production in Human Mononuclear Cells: The Effects of Non-Specific Phosphodiesterase Inhibition" 3344: 3188: 3147: 2827: 1212: 1210:
Ukena D, Schudt C, Sybrecht GW (February 1993). "Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes".
3296: 3113: 1548:"Powered by Skipta technology, PharmacistSociety.com is the social network for verified Pharmacists to communicate and collaborate" 3305: 3219: 3003: 2044:
Pöch, G.; Kukovetz, W.R. (1971). "Papaverine - induced inhibition of phosphodiesterase activity in various mammalian tissues".
3265: 3172: 164: 62: 58: 3359: 3193: 168: 3392: 3384: 2978: 727:
Weiss B.; Hait W.N. (1977). "Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents".
160: 673:
Weiss B (1975). "Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase".
3288: 3278: 3201: 3105: 2908: 700:
Fertel R, Weiss B (1976). "Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung".
3142: 3084: 3047: 2996: 464: 284: 75: 3408: 3231: 3097: 303: 1069:
Daly JW, Jacobson KA, Ukena D (1987). "Adenosine receptors: development of selective agonists and antagonists".
937:
Daly JW, Jacobson KA, Ukena D (1987). "Adenosine receptors: development of selective agonists and antagonists".
452:
and other inflammatory signals, and inhibit the production of reactive oxygen species. PDE4 inhibitors may have
3364: 3226: 3339: 3317: 3283: 3042: 2088: 507: 413: 390:, indicated for people with severe COPD to prevent symptoms such as coughing and excess mucus from worsening 603:
Thompson WJ, Appleman MM (1971). "Multiple cyclic nucleotide phosphodiesterase activities from rat brain".
3300: 3270: 3236: 3209: 3121: 3037: 2822: 515: 3349: 1933:
da Silva, F H; Pereira, M N; Franco-Penteado, C F; De Nucci, G; Antunes, E; Claudino, M A (March 2013).
327: 2661: 1726: 511: 198:
But different analogues show varying potency at the numerous subtypes, and a wide range of synthetic
1878:"Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans" 3214: 3129: 417: 347: 2958: 2523: 2423: 2413: 2383: 2320: 2250: 202:(some nonmethylated) have been developed in the search for compounds with greater selectivity for 3052: 2737: 2631: 2388: 1840: 1646: 1603: 1368: 1325: 207: 191: 2933: 2923: 2760: 2621: 2568: 2563: 2548: 2533: 2528: 2513: 2488: 2483: 2478: 2468: 2428: 2310: 2295: 2260: 2202: 578:, has been reported to act as a PDE10 inhibitor. PDE10A is almost exclusively expressed in the 2775: 2611: 3322: 2953: 2656: 2558: 2508: 2403: 2285: 2106: 2061: 2013: 1964: 1956: 1915: 1897: 1832: 1824: 1788: 1752: 1695: 1638: 1595: 1529: 1493: 1452: 1403: 1360: 1317: 1268: 1229: 1192: 1153: 1117: 1078: 1051: 946: 919: 875: 840: 788: 744: 709: 682: 655: 620: 433: 203: 180: 50: 2796: 2398: 3057: 3023: 2053: 2003: 1995: 1946: 1905: 1889: 1816: 1780: 1742: 1734: 1685: 1677: 1630: 1587: 1521: 1483: 1442: 1434: 1395: 1352: 1307: 1299: 1260: 1221: 1184: 1145: 1109: 1043: 973: 909: 867: 830: 822: 778: 736: 647: 612: 54: 17: 1470:
de Visser YP, Walther FJ, Laghmani EH, van Wijngaarden S, Nieuwland K, Wagenaar GT (2008).
3327: 3134: 2867: 2676: 1666:"Rolipram: A specific phosphodiesterase 4 inhibitor with potential antipsychotic activity" 1472:"Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury" 997: 280: 184: 2032: 1730: 1312: 740: 3180: 3167: 3074: 2862: 2636: 2616: 2588: 2360: 2227: 2008: 1984:"Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine" 1983: 1910: 1877: 1747: 1714: 1690: 1681: 1665: 1634: 1447: 1422: 835: 810: 477: 453: 336: 288: 262: 145: 130: 1264: 3427: 3310: 2943: 2903: 2812: 2596: 2057: 1893: 1225: 1113: 651: 457: 172: 122:(3-isobutyl-1-methylxanthine), used as investigative tool in pharmacological research 114: 1844: 1650: 1372: 826: 3019: 2938: 2877: 2842: 2832: 2742: 2498: 2438: 2280: 1607: 1329: 553: 525: 521: 342: 141: 125: 30: 2988: 78:
and Hait. This prediction meanwhile has proved to be true in a variety of fields.
1784: 1525: 1015: 871: 384:, used to alleviate renal colic pain, also to hasten cervical dilatation in labor 3157: 2918: 2913: 2872: 2837: 2765: 2732: 2646: 2578: 2538: 2518: 2473: 2433: 2418: 2350: 2345: 2265: 2255: 2197: 2179: 542: 425: 399: 387: 381: 365: 312:
is FDA approved for veterinary use in the treatment of heart failure in animals.
241: 176: 136: 2122: 1421:
Lim YH, Lee YY, Kim JH, Shin J, Lee JU, Kim KS, Kim SK, Kim JH, Lim HK (2010).
914: 897: 545:
type PDE7 inhibitor to be potent anti-inflammatory and neuroprotective agents.
2928: 2770: 2696: 2671: 2601: 2503: 2448: 2408: 2373: 2368: 2340: 2335: 2315: 2270: 2245: 1999: 1488: 1471: 1438: 1303: 583: 568: 491: 483: 393: 309: 299: 294: 43: 1960: 1901: 1828: 3250: 2948: 2882: 2847: 2780: 2714: 2686: 2666: 2641: 2463: 2443: 2325: 2305: 2300: 2275: 2235: 2174: 1858: 783: 766: 506:, which is cGMP-specific and responsible for the degradation of cGMP in the 487: 409: 359: 276: 272: 152: 109: 98: 2017: 1968: 1919: 1836: 1820: 1792: 1756: 1699: 1642: 1533: 1497: 1456: 1407: 1364: 1321: 1272: 1173:"Caffeine analogs: structure-activity relationships at adenosine receptors" 923: 844: 792: 524:
also inhibits PDE5. This results in added benefit when given together with
2065: 1599: 1233: 1196: 1157: 1121: 1082: 1055: 964:
MacCorquodale, DW (July 1929). "The Synthesis of Some Alkylxanthines1,2".
950: 879: 659: 624: 582:
and subsequent increase in cAMP and cGMP after PDE10A inhibition (e.g. by
2963: 2898: 2857: 2817: 2691: 2606: 2543: 2493: 2453: 2378: 2240: 2212: 1982:
Weber M, Breier M, Ko D, Thangaraj N, Marzan DE, Swerdlow NR (May 2009).
1951: 1934: 713: 686: 579: 575: 557: 514:, as well as having some other medical applications such as treatment of 510:. These phosphodiesterase inhibitors are used primarily as remedies for 499: 495: 449: 445: 405: 371: 353: 268: 247: 199: 105: 1738: 1149: 1047: 977: 748: 616: 2651: 2626: 2553: 2458: 2393: 2330: 1591: 1399: 1356: 1188: 586:) is "a novel therapeutic avenue in the discovery of antipsychotics". 3089: 2681: 2573: 2290: 1664:
Kanes SJ, Tokarczyk J, Siegel SJ, Bilker W, Abel T, Kelly MP (2006).
898:"Leukotrienes: underappreciated mediators of innate immune responses" 529: 437: 421: 47: 1287: 1248: 1172: 1097: 252:
PDP (9-(6-Phenyl-2-oxohex-3-yl)-2-(3,4-dimethoxybenzyl)-purin-6-one)
3374: 2790: 2752: 572: 375: 326: 29: 2081: 2852: 2724: 2706: 2207: 2189: 2161: 503: 316: 219: 119: 53:(PDE), thereby preventing the inactivation of the intracellular 2992: 2126: 809:
Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R (2008).
2804: 319:
is sometimes referred to as cGMP-inhibited phosphodiesterase.
1715:"Sleep deprivation impairs cAMP signaling in the hippocampus" 1010:
Constantin Koulbanis, Claude Bouillon, Patrick Darmenton,
896:
Peters-Golden M, Canetti C, Mancuso P, Coffey MJ (2005).
374:, supplement extracted from peanuts that also possesses 356:, used as investigative tool in pharmacological research 244:(2--7--4-phenylbutyl]-5-methyl-imidazotriazin-4(1H)-one) 2033:
http://www.jstage.jst.go.jp/article/jphs/98/3/275/_pdf
1578:
in hospitalized major and/or endogenous depressives".
46:
that blocks one or more of the five subtypes of the
3401: 3373: 3249: 3156: 3073: 3066: 3030: 2891: 2803: 2789: 2751: 2723: 2705: 2587: 2359: 2226: 2188: 2160: 891: 889: 396:, used to treat psoriasis and psoriatic arthritis. 1096:Choi OH, Shamim MT, Padgett WL, Daly JW (1988). 1012:"Cosmetic compositions having a slimming action" 279:are used clinically for short-term treatment of 456:effects and have also been proposed for use as 771:The Journal of Allergy and Clinical Immunology 760: 758: 3004: 2138: 1171:Daly JW, Hide I, Müller CE, Shamim M (1991). 8: 1071:Progress in Clinical and Biological Research 1939:International Journal of Impotence Research 804: 802: 3070: 3011: 2997: 2989: 2145: 2131: 2123: 1018:, granted 1981-09-04 , assigned to L'Oreal 2007: 1950: 1909: 1746: 1689: 1487: 1446: 1311: 913: 834: 782: 74:agents was predicted as early as 1977 by 966:Journal of the American Chemical Society 368:, a more potent inhibitor than rolipram. 1253:Journal of the Autonomic Nervous System 595: 424:positive allosteric modulator, used as 2111:: CS1 maint: archived copy as title ( 2104: 767:"Cyclic nucleotide phosphodiesterases" 412:alkaloid, low-potency PDE4 inhibitor, 1288:"Caffeine analogs: biomedical impact" 7: 1292:Cellular and Molecular Life Sciences 88:List of phosphodiesterase inhibitors 741:10.1146/annurev.pa.17.040177.002301 1682:10.1016/j.neuroscience.2006.09.026 1635:10.1016/j.neuroscience.2004.07.038 1249:"Alkylxanthines as research tools" 402:, used to treat atopic dermatitis. 25: 1894:10.1016/j.neuropharm.2012.11.029 2094:from the original on 2011-10-07 827:10.1590/S1807-59322008000300006 448:. They suppress the release of 1580:Eur Arch Psychiatry Neurol Sci 1138:Journal of Medicinal Chemistry 1036:Journal of Medicinal Chemistry 428:in Eastern Europe and Iceland. 63:cyclic guanosine monophosphate 59:cyclic adenosine monophosphate 1: 2979:Receptor/signaling modulators 1265:10.1016/S0165-1838(00)00110-7 860:Am. J. Respir. Crit. Care Med 729:Annu. Rev. Pharmacol. Toxicol 3434:Phosphodiesterase inhibitors 2154:Phosphodiesterase inhibitors 2058:10.1016/0024-3205(71)90086-5 1785:10.1016/j.ejmech.2011.10.040 1552:pharmacistsociety.skipta.com 1526:10.1016/j.ejphar.2009.10.031 1226:10.1016/0006-2952(93)90168-V 1114:10.1016/0024-3205(88)90517-6 872:10.1164/ajrccm.159.2.9804085 652:10.1016/0005-2744(72)90060-5 345:, an alkaloid from the herb 302:is used in the treatment of 163:, which raise intracellular 161:phosphodiesterase inhibitors 18:Phosphodiesterase inhibitors 1016:US patent 4288433 93:Nonselective PDE inhibitors 40:phosphodiesterase inhibitor 3450: 3189:Dihydropteroate synthetase 3048:Non-competitive inhibition 1345:Medicinal Research Reviews 915:10.4049/jimmunol.174.2.589 564:PDE10 selective inhibitors 541:Recent studies have shown 475: 465:University of Pennsylvania 334: 260: 85: 3409:Steroidogenesis inhibitor 2972: 2000:10.1007/s00213-008-1419-x 1489:10.1183/09031936.00071307 1439:10.5045/kjh.2010.45.2.136 1304:10.1007/s00018-007-7051-9 556:, the main metabolite of 549:PDE9 selective inhibitors 537:PDE7 selective inhibitors 472:PDE5 selective inhibitors 463:On October 26, 2009, the 323:PDE4 selective inhibitors 304:intermittent claudication 287:stimulation and increase 257:PDE3 selective inhibitors 214:PDE2 selective inhibitors 159:competitive nonselective 3345:Matrix metalloproteinase 3148:Ribonucleotide reductase 3043:Uncompetitive inhibition 1213:Biochemical Pharmacology 204:phosphodiesterase enzyme 3114:Dihydrofolate reductase 1286:Daly JW (August 2007). 784:10.1067/mai.2001.119555 414:calcium channel blocker 3210:Nucleotidyltransferase 3038:Competitive inhibition 2823:Choline theophyllinate 1821:10.1124/mol.108.048207 1809:Molecular Pharmacology 640:Biochim. Biophys. Acta 516:pulmonary hypertension 332: 35: 3220:Reverse transcriptase 2241:Amrinone (inamrinone) 1247:Daly JW (July 2000). 902:Journal of Immunology 330: 283:. These drugs mimic 33: 3266:Acetylcholinesterase 3173:Thymidylate synthase 1952:10.1038/ijir.2012.35 991:WO patent 1985002540 765:Essayan DM. (2001). 675:Adv. Cycl. Nucl. Res 512:erectile dysfunction 502:selectively inhibit 200:xanthine derivatives 3360:Histone deacetylase 3194:Farnesyltransferase 1739:10.1038/nature08488 1731:2009Natur.461.1122V 1725:(7267): 1122–1125. 1150:10.1021/jm00126a014 1048:10.1021/jm00157a035 978:10.1021/ja01382a042 815:Clinics (Sao Paulo) 617:10.1021/bi00778a018 418:dopamine antagonist 348:Sceletium tortuosum 181:reduce inflammation 34:Phosphodiesterase-5 3393:Carbonic anhydrase 3385:Dopa decarboxylase 3053:Suicide inhibition 1988:Psychopharmacology 1592:10.1007/BF00381071 996:2011-08-05 at the 939:Prog Clin Biol Res 434:pulmonary diseases 333: 208:adenosine receptor 192:adenosine receptor 36: 3421: 3420: 3417: 3416: 3289:Alpha-glucosidase 3279:Polygalacturonase 3261:Phosphodiesterase 3202:GABA transaminase 3106:Monoamine oxidase 3090:HMG-CoA reductase 3024:enzyme inhibition 2986: 2985: 2657:Nitrosoprodenafil 1882:Neuropharmacology 1400:10.1021/cr0682195 1357:10.1002/med.20108 1189:10.1159/000138813 508:corpus cavernosum 173:inhibit TNF-alpha 101:and derivatives: 55:second messengers 51:phosphodiesterase 16:(Redirected from 3441: 3143:Xanthine oxidase 3085:Aldose reductase 3071: 3058:Mixed inhibition 3013: 3006: 2999: 2990: 2147: 2140: 2133: 2124: 2117: 2116: 2110: 2102: 2100: 2099: 2093: 2086: 2076: 2070: 2069: 2041: 2035: 2028: 2022: 2021: 2011: 1979: 1973: 1972: 1954: 1930: 1924: 1923: 1913: 1872: 1866: 1865: 1863: 1855: 1849: 1848: 1803: 1797: 1796: 1767: 1761: 1760: 1750: 1710: 1704: 1703: 1693: 1661: 1655: 1654: 1618: 1612: 1611: 1574: 1568: 1567: 1565: 1563: 1558:on 19 April 2012 1554:. Archived from 1544: 1538: 1537: 1508: 1502: 1501: 1491: 1467: 1461: 1460: 1450: 1427:Korean J Hematol 1418: 1412: 1411: 1388:Chemical Reviews 1383: 1377: 1376: 1340: 1334: 1333: 1315: 1283: 1277: 1276: 1244: 1238: 1237: 1207: 1201: 1200: 1168: 1162: 1161: 1132: 1126: 1125: 1093: 1087: 1086: 1066: 1060: 1059: 1031: 1025: 1024: 1023: 1019: 1007: 1001: 988: 982: 981: 972:(7): 2245–2251. 961: 955: 954: 934: 928: 927: 917: 893: 884: 883: 855: 849: 848: 838: 806: 797: 796: 786: 762: 753: 752: 724: 718: 717: 697: 691: 690: 670: 664: 663: 635: 629: 628: 600: 494:, and the newer 21: 3449: 3448: 3444: 3443: 3442: 3440: 3439: 3438: 3424: 3423: 3422: 3413: 3397: 3369: 3245: 3232:Tyrosine kinase 3152: 3062: 3026: 3017: 2987: 2982: 2968: 2887: 2868:Propentofylline 2799: 2785: 2747: 2719: 2701: 2677:Sulfoaildenafil 2662:Norcarbodenafil 2583: 2355: 2222: 2184: 2156: 2151: 2121: 2120: 2103: 2097: 2095: 2091: 2084: 2082:"Archived copy" 2080: 2077: 2073: 2043: 2042: 2038: 2029: 2025: 1981: 1980: 1976: 1932: 1931: 1927: 1874: 1873: 1869: 1861: 1857: 1856: 1852: 1805: 1804: 1800: 1769: 1768: 1764: 1712: 1711: 1707: 1663: 1662: 1658: 1620: 1619: 1615: 1576: 1575: 1571: 1561: 1559: 1546: 1545: 1541: 1520:(1–3): 269–75. 1514:Eur J Pharmacol 1510: 1509: 1505: 1469: 1468: 1464: 1420: 1419: 1415: 1385: 1384: 1380: 1342: 1341: 1337: 1298:(16): 2153–69. 1285: 1284: 1280: 1246: 1245: 1241: 1209: 1208: 1204: 1170: 1169: 1165: 1134: 1133: 1129: 1095: 1094: 1090: 1068: 1067: 1063: 1033: 1032: 1028: 1021: 1009: 1008: 1004: 998:Wayback Machine 989: 985: 963: 962: 958: 936: 935: 931: 895: 894: 887: 857: 856: 852: 808: 807: 800: 764: 763: 756: 726: 725: 721: 699: 698: 694: 672: 671: 667: 637: 636: 632: 602: 601: 597: 592: 566: 551: 539: 480: 474: 339: 331:PDE4 inhibitors 325: 281:cardiac failure 265: 259: 216: 185:innate immunity 179:synthesis, and 95: 90: 84: 71: 28: 23: 22: 15: 12: 11: 5: 3447: 3445: 3437: 3436: 3426: 3425: 3419: 3418: 3415: 3414: 3412: 3411: 3405: 3403: 3399: 3398: 3396: 3395: 3388: 3387: 3380: 3378: 3371: 3370: 3368: 3367: 3365:Beta-lactamase 3362: 3355: 3354: 3353: 3352: 3347: 3342: 3332: 3331: 3330: 3325: 3315: 3314: 3313: 3308: 3292: 3291: 3286: 3281: 3274: 3273: 3268: 3263: 3256: 3254: 3247: 3246: 3244: 3243: 3242: 3241: 3240: 3239: 3227:Protein kinase 3224: 3223: 3222: 3217: 3205: 3204: 3197: 3196: 3191: 3184: 3183: 3176: 3175: 3170: 3163: 3161: 3154: 3153: 3151: 3150: 3145: 3138: 3137: 3132: 3125: 3124: 3117: 3116: 3109: 3108: 3101: 3100: 3093: 3092: 3087: 3080: 3078: 3075:Oxidoreductase 3068: 3064: 3063: 3061: 3060: 3055: 3050: 3045: 3040: 3034: 3032: 3028: 3027: 3018: 3016: 3015: 3008: 3001: 2993: 2984: 2983: 2973: 2970: 2969: 2967: 2966: 2961: 2956: 2951: 2946: 2941: 2936: 2931: 2926: 2921: 2916: 2911: 2906: 2901: 2895: 2893: 2889: 2888: 2886: 2885: 2880: 2875: 2870: 2865: 2863:Pentoxifylline 2860: 2855: 2850: 2845: 2840: 2835: 2830: 2825: 2820: 2815: 2809: 2807: 2801: 2800: 2795: 2793: 2787: 2786: 2784: 2783: 2778: 2773: 2768: 2763: 2757: 2755: 2749: 2748: 2746: 2745: 2740: 2735: 2729: 2727: 2721: 2720: 2718: 2717: 2711: 2709: 2703: 2702: 2700: 2699: 2694: 2689: 2684: 2679: 2674: 2669: 2664: 2659: 2654: 2649: 2644: 2639: 2637:Homosildenafil 2634: 2629: 2624: 2619: 2617:Benzamidenafil 2614: 2609: 2604: 2599: 2593: 2591: 2585: 2584: 2582: 2581: 2576: 2571: 2566: 2561: 2556: 2551: 2546: 2541: 2536: 2531: 2526: 2521: 2516: 2511: 2506: 2501: 2496: 2491: 2486: 2481: 2476: 2471: 2466: 2461: 2456: 2451: 2446: 2441: 2436: 2431: 2426: 2421: 2416: 2411: 2406: 2401: 2396: 2391: 2386: 2381: 2376: 2371: 2365: 2363: 2357: 2356: 2354: 2353: 2348: 2343: 2338: 2333: 2328: 2323: 2318: 2313: 2308: 2303: 2298: 2293: 2288: 2283: 2278: 2273: 2268: 2263: 2258: 2253: 2248: 2243: 2238: 2232: 2230: 2224: 2223: 2221: 2220: 2215: 2210: 2205: 2200: 2194: 2192: 2186: 2185: 2183: 2182: 2177: 2172: 2166: 2164: 2158: 2157: 2152: 2150: 2149: 2142: 2135: 2127: 2119: 2118: 2071: 2052:(3): 133–144. 2036: 2023: 1974: 1925: 1867: 1859:"Paraxanthine" 1850: 1815:(4): 980–989. 1798: 1773:Eur J Med Chem 1762: 1705: 1656: 1613: 1569: 1539: 1503: 1482:(3): 633–644. 1462: 1413: 1378: 1335: 1278: 1259:(1–3): 44–52. 1239: 1202: 1163: 1127: 1088: 1061: 1026: 1002: 983: 956: 929: 885: 850: 798: 754: 719: 708:(4): 678–687. 702:Mol. Pharmacol 692: 665: 646:(1): 220–226. 630: 594: 593: 591: 588: 565: 562: 550: 547: 538: 535: 534: 533: 519: 478:PDE5 inhibitor 476:Main article: 473: 470: 458:antipsychotics 454:antidepressive 430: 429: 403: 397: 391: 385: 379: 369: 363: 357: 351: 337:PDE4 inhibitor 335:Main article: 324: 321: 314: 313: 307: 297: 292: 289:cardiac output 263:PDE3 inhibitor 261:Main article: 258: 255: 254: 253: 250: 245: 239: 215: 212: 196: 195: 188: 149: 148: 146:bronchodilator 139: 134: 131:pentoxifylline 128: 123: 117: 112: 94: 91: 83: 82:Classification 80: 70: 67: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 3446: 3435: 3432: 3431: 3429: 3410: 3407: 3406: 3404: 3402:Miscellaneous 3400: 3394: 3390: 3389: 3386: 3382: 3381: 3379: 3376: 3372: 3366: 3363: 3361: 3357: 3356: 3351: 3348: 3346: 3343: 3341: 3340:Enkephalinase 3338: 3337: 3336: 3333: 3329: 3326: 3324: 3321: 3320: 3319: 3318:Endopeptidase 3316: 3312: 3309: 3307: 3304: 3303: 3302: 3298: 3294: 3293: 3290: 3287: 3285: 3284:Neuraminidase 3282: 3280: 3276: 3275: 3272: 3269: 3267: 3264: 3262: 3258: 3257: 3255: 3252: 3248: 3238: 3235: 3234: 3233: 3230: 3229: 3228: 3225: 3221: 3218: 3216: 3213: 3212: 3211: 3207: 3206: 3203: 3199: 3198: 3195: 3192: 3190: 3186: 3185: 3182: 3178: 3177: 3174: 3171: 3169: 3165: 3164: 3162: 3159: 3155: 3149: 3146: 3144: 3140: 3139: 3136: 3133: 3131: 3127: 3126: 3123: 3119: 3118: 3115: 3111: 3110: 3107: 3103: 3102: 3099: 3095: 3094: 3091: 3088: 3086: 3082: 3081: 3079: 3076: 3072: 3069: 3065: 3059: 3056: 3054: 3051: 3049: 3046: 3044: 3041: 3039: 3036: 3035: 3033: 3029: 3025: 3021: 3014: 3009: 3007: 3002: 3000: 2995: 2994: 2991: 2981: 2980: 2977: 2971: 2965: 2962: 2960: 2957: 2955: 2952: 2950: 2947: 2945: 2944:Proxyphylline 2942: 2940: 2937: 2935: 2932: 2930: 2927: 2925: 2922: 2920: 2917: 2915: 2912: 2910: 2907: 2905: 2904:Diprophylline 2902: 2900: 2897: 2896: 2894: 2890: 2884: 2881: 2879: 2876: 2874: 2871: 2869: 2866: 2864: 2861: 2859: 2856: 2854: 2851: 2849: 2846: 2844: 2841: 2839: 2836: 2834: 2831: 2829: 2826: 2824: 2821: 2819: 2816: 2814: 2813:Aminophylline 2811: 2810: 2808: 2806: 2805:Non-selective 2802: 2798: 2794: 2792: 2788: 2782: 2779: 2777: 2774: 2772: 2769: 2767: 2764: 2762: 2759: 2758: 2756: 2754: 2750: 2744: 2741: 2739: 2736: 2734: 2731: 2730: 2728: 2726: 2722: 2716: 2713: 2712: 2710: 2708: 2704: 2698: 2695: 2693: 2690: 2688: 2685: 2683: 2680: 2678: 2675: 2673: 2670: 2668: 2665: 2663: 2660: 2658: 2655: 2653: 2650: 2648: 2645: 2643: 2640: 2638: 2635: 2633: 2630: 2628: 2625: 2623: 2620: 2618: 2615: 2613: 2610: 2608: 2605: 2603: 2600: 2598: 2597:Acetildenafil 2595: 2594: 2592: 2590: 2586: 2580: 2577: 2575: 2572: 2570: 2567: 2565: 2562: 2560: 2557: 2555: 2552: 2550: 2547: 2545: 2542: 2540: 2537: 2535: 2532: 2530: 2527: 2525: 2522: 2520: 2517: 2515: 2512: 2510: 2507: 2505: 2502: 2500: 2497: 2495: 2492: 2490: 2487: 2485: 2482: 2480: 2477: 2475: 2472: 2470: 2467: 2465: 2462: 2460: 2457: 2455: 2452: 2450: 2447: 2445: 2442: 2440: 2437: 2435: 2432: 2430: 2427: 2425: 2422: 2420: 2417: 2415: 2412: 2410: 2407: 2405: 2402: 2400: 2397: 2395: 2392: 2390: 2387: 2385: 2382: 2380: 2377: 2375: 2372: 2370: 2367: 2366: 2364: 2362: 2358: 2352: 2349: 2347: 2344: 2342: 2339: 2337: 2334: 2332: 2329: 2327: 2324: 2322: 2319: 2317: 2314: 2312: 2309: 2307: 2304: 2302: 2299: 2297: 2294: 2292: 2289: 2287: 2284: 2282: 2279: 2277: 2274: 2272: 2269: 2267: 2264: 2262: 2259: 2257: 2254: 2252: 2249: 2247: 2244: 2242: 2239: 2237: 2234: 2233: 2231: 2229: 2225: 2219: 2216: 2214: 2211: 2209: 2206: 2204: 2201: 2199: 2196: 2195: 2193: 2191: 2187: 2181: 2178: 2176: 2173: 2171: 2168: 2167: 2165: 2163: 2159: 2155: 2148: 2143: 2141: 2136: 2134: 2129: 2128: 2125: 2114: 2108: 2090: 2083: 2075: 2072: 2067: 2063: 2059: 2055: 2051: 2047: 2046:Life Sciences 2040: 2037: 2034: 2027: 2024: 2019: 2015: 2010: 2005: 2001: 1997: 1994:(4): 723–35. 1993: 1989: 1985: 1978: 1975: 1970: 1966: 1962: 1958: 1953: 1948: 1944: 1940: 1936: 1929: 1926: 1921: 1917: 1912: 1907: 1903: 1899: 1895: 1891: 1887: 1883: 1879: 1871: 1868: 1860: 1854: 1851: 1846: 1842: 1838: 1834: 1830: 1826: 1822: 1818: 1814: 1810: 1802: 1799: 1794: 1790: 1786: 1782: 1779:(1): 175–85. 1778: 1774: 1766: 1763: 1758: 1754: 1749: 1744: 1740: 1736: 1732: 1728: 1724: 1720: 1716: 1709: 1706: 1701: 1697: 1692: 1687: 1683: 1679: 1676:(1): 239–46. 1675: 1671: 1667: 1660: 1657: 1652: 1648: 1644: 1640: 1636: 1632: 1628: 1624: 1617: 1614: 1609: 1605: 1601: 1597: 1593: 1589: 1585: 1581: 1573: 1570: 1557: 1553: 1549: 1543: 1540: 1535: 1531: 1527: 1523: 1519: 1515: 1507: 1504: 1499: 1495: 1490: 1485: 1481: 1477: 1473: 1466: 1463: 1458: 1454: 1449: 1444: 1440: 1436: 1432: 1428: 1424: 1417: 1414: 1409: 1405: 1401: 1397: 1394:(1): 238–63. 1393: 1389: 1382: 1379: 1374: 1370: 1366: 1362: 1358: 1354: 1351:(3): 329–71. 1350: 1346: 1339: 1336: 1331: 1327: 1323: 1319: 1314: 1309: 1305: 1301: 1297: 1293: 1289: 1282: 1279: 1274: 1270: 1266: 1262: 1258: 1254: 1250: 1243: 1240: 1235: 1231: 1227: 1223: 1220:(4): 847–51. 1219: 1215: 1214: 1206: 1203: 1198: 1194: 1190: 1186: 1183:(6): 309–21. 1182: 1178: 1174: 1167: 1164: 1159: 1155: 1151: 1147: 1144:(6): 1231–7. 1143: 1139: 1131: 1128: 1123: 1119: 1115: 1111: 1108:(5): 387–98. 1107: 1103: 1102:Life Sciences 1099: 1092: 1089: 1084: 1080: 1076: 1072: 1065: 1062: 1057: 1053: 1049: 1045: 1042:(7): 1305–8. 1041: 1037: 1030: 1027: 1017: 1013: 1006: 1003: 999: 995: 992: 987: 984: 979: 975: 971: 967: 960: 957: 952: 948: 944: 940: 933: 930: 925: 921: 916: 911: 908:(2): 589–94. 907: 903: 899: 892: 890: 886: 881: 877: 873: 869: 866:(2): 508–11. 865: 861: 854: 851: 846: 842: 837: 832: 828: 824: 820: 816: 812: 805: 803: 799: 794: 790: 785: 780: 777:(5): 671–80. 776: 772: 768: 761: 759: 755: 750: 746: 742: 738: 734: 730: 723: 720: 715: 711: 707: 703: 696: 693: 688: 684: 680: 676: 669: 666: 661: 657: 653: 649: 645: 641: 634: 631: 626: 622: 618: 614: 610: 606: 599: 596: 589: 587: 585: 581: 577: 574: 570: 563: 561: 559: 555: 548: 546: 544: 536: 531: 527: 523: 520: 517: 513: 509: 505: 501: 497: 493: 489: 485: 482: 481: 479: 471: 469: 466: 461: 459: 455: 451: 447: 443: 439: 435: 427: 423: 419: 415: 411: 407: 404: 401: 398: 395: 392: 389: 386: 383: 380: 377: 373: 370: 367: 364: 361: 358: 355: 352: 350: 349: 344: 341: 340: 338: 329: 322: 320: 318: 311: 308: 305: 301: 298: 296: 293: 290: 286: 282: 278: 274: 270: 267: 266: 264: 256: 251: 249: 246: 243: 240: 237: 233: 229: 225: 221: 218: 217: 213: 211: 209: 205: 201: 193: 190:nonselective 189: 186: 182: 178: 174: 170: 166: 162: 158: 157: 156: 154: 147: 143: 140: 138: 135: 132: 129: 127: 124: 121: 118: 116: 115:aminophylline 113: 111: 107: 104: 103: 102: 100: 92: 89: 81: 79: 77: 68: 66: 64: 60: 56: 52: 49: 45: 41: 32: 19: 3334: 3301:Exopeptidase 3271:Ribonuclease 3260: 3237:Janus kinase 3122:Lipoxygenase 3098:5α-Reductase 3020:Pharmacology 2975: 2974: 2959:Tolafentrine 2939:Pentifylline 2878:Theophylline 2843:Enprofylline 2833:Dipyridamole 2743:Paraxanthine 2524:Pumafentrine 2499:Mesembrenone 2439:Ensifentrine 2424:Denbutylline 2414:Cipamfylline 2384:Benafentrine 2321:Pumafentrine 2281:Ensifentrine 2251:Benafentrine 2153: 2096:. Retrieved 2074: 2049: 2045: 2039: 2026: 1991: 1987: 1977: 1945:(2): 69–73. 1942: 1938: 1928: 1885: 1881: 1870: 1853: 1812: 1808: 1801: 1776: 1772: 1765: 1722: 1718: 1708: 1673: 1670:Neuroscience 1669: 1659: 1629:(1): 101–7. 1626: 1623:Neuroscience 1622: 1616: 1583: 1579: 1572: 1560:. Retrieved 1556:the original 1551: 1542: 1517: 1513: 1506: 1479: 1476:Eur Respir J 1475: 1465: 1433:(2): 136–8. 1430: 1426: 1416: 1391: 1387: 1381: 1348: 1344: 1338: 1295: 1291: 1281: 1256: 1252: 1242: 1217: 1211: 1205: 1180: 1177:Pharmacology 1176: 1166: 1141: 1137: 1130: 1105: 1101: 1091: 1074: 1070: 1064: 1039: 1035: 1029: 1011: 1005: 986: 969: 965: 959: 945:(1): 41–63. 942: 938: 932: 905: 901: 863: 859: 853: 821:(3): 321–8. 818: 814: 774: 770: 732: 728: 722: 705: 701: 695: 678: 674: 668: 643: 639: 633: 611:(2): 311–6. 608: 605:Biochemistry 604: 598: 567: 554:Paraxanthine 552: 540: 526:nitric oxide 522:Dipyridamole 462: 431: 346: 343:Mesembrenone 315: 235: 231: 227: 226:rythro-9-(2- 223: 197: 155:act as both 150: 142:theophylline 126:paraxanthine 96: 72: 39: 37: 3350:Oxytocinase 3158:Transferase 2919:Lisofylline 2914:Furafylline 2873:Theobromine 2838:Doxofylline 2766:Mardepodect 2738:PF-04447943 2733:BAY 73-6691 2647:Mirodenafil 2632:Gisadenafil 2579:Zardaverine 2539:Roflumilast 2519:Piclamilast 2474:Irsogladine 2434:Drotaverine 2419:Crisaborole 2389:Catramilast 2351:Zardaverine 2346:Vesnarinone 2266:Cilostamide 2256:Bucladesine 2198:BAY 60-7550 2180:Vinpocetine 1888:: 476–484. 735:: 441–477. 681:: 195–211. 543:quinazoline 426:antitussive 400:Crisaborole 388:Roflumilast 382:Drotaverine 378:properties. 366:Piclamilast 285:sympathetic 242:BAY 60-7550 194:antagonists 177:leukotriene 167:, activate 151:Methylated 137:theobromine 97:Methylated 61:(cAMP) and 2934:Oxagrelate 2929:Moxaverine 2924:MDL-12330A 2771:Papaverine 2761:Balipodect 2697:Vardenafil 2672:Sildenafil 2622:Dasantafil 2602:Aildenafil 2569:Tofimilast 2564:Tetomilast 2549:Ronomilast 2534:Ro 20-1724 2529:Revamilast 2514:Oglemilast 2504:Mesembrine 2489:Lotamilast 2484:Lirimilast 2479:Lavamilast 2469:Indimilast 2449:Filaminast 2429:Difamilast 2409:Cilomilast 2374:Arofylline 2369:Apremilast 2341:Trequinsin 2336:Siguazodan 2316:Pimobendan 2311:Parogrelil 2296:Meribendan 2271:Cilostazol 2261:Carbazeran 2246:Anagrelide 2203:Carbazeran 2098:2011-08-27 1586:(1): 2–6. 590:References 584:papaverine 569:Papaverine 492:vardenafil 484:Sildenafil 394:Apremilast 310:Pimobendan 300:Cilostazol 295:Anagrelide 210:subtypes. 108:, a minor 86:See also: 3251:Hydrolase 3215:Integrase 3130:Aromatase 3067:Substrate 2976:See also: 2949:Quercetin 2883:Zaprinast 2848:Ibudilast 2781:Tofisopam 2776:TC-E 5005 2715:BRL-50481 2687:Tadalafil 2667:SCH-51866 2642:Lodenafil 2612:Beminafil 2464:ICI-63197 2444:Etazolate 2326:Quazinone 2306:Olprinone 2301:Milrinone 2276:Enoximone 2236:Adibendan 2175:SCH-51866 1961:0955-9930 1902:0028-3908 1829:1521-0111 1077:: 41–63. 488:tadalafil 450:cytokines 410:aporphine 360:Ibudilast 277:enoximone 273:milrinone 230:ydroxy-3- 153:xanthines 110:stimulant 99:xanthines 3428:Category 3297:Protease 2964:Trapidil 2954:Satigrel 2899:Diazepam 2892:Unsorted 2858:Luteolin 2818:Caffeine 2692:Udenafil 2607:Avanafil 2559:RS-25344 2544:Rolipram 2509:Mesopram 2494:Luteolin 2454:Glaucine 2404:CGH-2466 2379:Atizoram 2286:Imazodan 2213:Oxindole 2107:cite web 2089:Archived 2018:19066855 1969:23034509 1920:23261866 1845:14842240 1837:18621927 1793:22100138 1757:19847264 1700:17081698 1651:19578277 1643:15489033 1534:19853596 1498:18094015 1457:21120194 1408:18181659 1373:23923058 1365:17668454 1322:17514358 1313:11138448 1273:10869699 994:Archived 924:15634873 845:18568240 793:11692087 580:striatum 576:alkaloid 558:caffeine 500:avanafil 496:udenafil 446:rhinitis 436:such as 406:Glaucine 372:Luteolin 354:Rolipram 269:Amrinone 248:Oxindole 106:caffeine 3323:Trypsin 2797:BC11-38 2652:MY-5445 2627:Icariin 2554:RPL-554 2459:HT-0712 2399:CDP-840 2394:CC-1088 2331:RPL-554 2066:4325052 2009:2748940 1911:3562388 1748:2783639 1727:Bibcode 1691:3313447 1608:7795640 1600:3063534 1448:2983030 1330:9866539 1234:7680859 1197:1658821 1158:2724296 1122:2456442 1083:3588607 1056:3806581 951:3588607 880:9927365 836:2664230 660:4342220 625:4321663 530:statins 238:denine) 69:History 3377:(EC 4) 3253:(EC 3) 3160:(EC 2) 3120:1.13 3077:(EC 1) 2682:T-0156 2574:YM-976 2291:KMUP-1 2064:  2016:  2006:  1967:  1959:  1918:  1908:  1900:  1843:  1835:  1827:  1791:  1755:  1745:  1719:Nature 1698:  1688:  1649:  1641:  1606:  1598:  1532:  1496:  1455:  1445:  1406:  1371:  1363:  1328:  1320:  1310:  1271:  1232:  1195:  1156:  1120:  1081:  1054:  1022:  949:  922:  878:  843:  833:  791:  747:  714:183099 712:  687:165666 685:  658:  623:  444:, and 438:asthma 422:5-HT2A 48:enzyme 3375:Lyase 3335:Mixed 3328:Renin 3306:DPP-4 3141:1.17 3135:COX-2 3128:1.14 3031:Class 2909:DPCPX 2791:PDE11 2753:PDE10 2092:(PDF) 2085:(PDF) 1862:(PDF) 1841:S2CID 1647:S2CID 1604:S2CID 1562:1 May 1369:S2CID 1326:S2CID 749:17360 573:opium 571:, an 408:, an 376:IGF-1 234:onyl) 76:Weiss 42:is a 3391:4.2 3383:4.1 3358:3.5 3295:3.4 3277:3.2 3259:3.1 3208:2.7 3200:2.6 3187:2.5 3181:PARP 3179:2.4 3168:COMT 3166:2.1 3112:1.5 3104:1.4 3096:1.3 3083:1.1 2853:IBMX 2725:PDE9 2707:PDE7 2589:PDE5 2361:PDE4 2228:PDE3 2208:EHNA 2190:PDE2 2170:MMPX 2162:PDE1 2113:link 2062:PMID 2014:PMID 1965:PMID 1957:ISSN 1916:PMID 1898:ISSN 1833:PMID 1825:ISSN 1789:PMID 1753:PMID 1696:PMID 1639:PMID 1596:PMID 1564:2018 1530:PMID 1494:PMID 1453:PMID 1404:PMID 1361:PMID 1318:PMID 1269:PMID 1230:PMID 1193:PMID 1154:PMID 1118:PMID 1079:PMID 1052:PMID 947:PMID 920:PMID 876:PMID 841:PMID 789:PMID 745:PMID 710:PMID 683:PMID 656:PMID 621:PMID 504:PDE5 498:and 442:COPD 420:and 317:PDE3 275:and 220:EHNA 183:and 175:and 165:cAMP 144:, a 120:IBMX 44:drug 27:Drug 3311:ACE 2828:CPX 2218:PDP 2054:doi 2004:PMC 1996:doi 1992:203 1947:doi 1906:PMC 1890:doi 1886:67C 1817:doi 1781:doi 1743:PMC 1735:doi 1723:461 1686:PMC 1678:doi 1674:144 1631:doi 1627:129 1588:doi 1584:238 1522:doi 1518:627 1484:doi 1443:PMC 1435:doi 1396:doi 1392:108 1353:doi 1308:PMC 1300:doi 1261:doi 1222:doi 1185:doi 1146:doi 1110:doi 1075:230 1044:doi 974:doi 943:230 910:doi 906:174 868:doi 864:159 831:PMC 823:doi 779:doi 775:108 737:doi 648:doi 644:284 613:doi 528:or 206:or 187:and 169:PKA 3430:: 3299:: 3022:: 2109:}} 2105:{{ 2087:. 2060:. 2050:10 2048:. 2012:. 2002:. 1990:. 1986:. 1963:. 1955:. 1943:25 1941:. 1937:. 1914:. 1904:. 1896:. 1884:. 1880:. 1839:. 1831:. 1823:. 1813:74 1811:. 1787:. 1777:47 1775:. 1751:. 1741:. 1733:. 1721:. 1717:. 1694:. 1684:. 1672:. 1668:. 1645:. 1637:. 1625:. 1602:. 1594:. 1582:. 1550:. 1528:. 1516:. 1492:. 1480:31 1478:. 1474:. 1451:. 1441:. 1431:45 1429:. 1425:. 1402:. 1390:. 1367:. 1359:. 1349:28 1347:. 1324:. 1316:. 1306:. 1296:64 1294:. 1290:. 1267:. 1257:81 1255:. 1251:. 1228:. 1218:45 1216:. 1191:. 1181:42 1179:. 1175:. 1152:. 1142:32 1140:. 1116:. 1106:43 1104:. 1100:. 1073:. 1050:. 1040:29 1038:. 1014:, 970:51 968:. 941:. 918:. 904:. 900:. 888:^ 874:. 862:. 839:. 829:. 819:63 817:. 813:. 801:^ 787:. 773:. 769:. 757:^ 743:. 733:17 731:. 706:12 704:. 677:. 654:. 642:. 619:. 609:10 607:. 490:, 486:, 460:. 440:, 416:, 271:, 171:, 57:, 38:A 3012:e 3005:t 2998:v 2146:e 2139:t 2132:v 2115:) 2101:. 2068:. 2056:: 2020:. 1998:: 1971:. 1949:: 1922:. 1892:: 1864:. 1847:. 1819:: 1795:. 1783:: 1759:. 1737:: 1729:: 1702:. 1680:: 1653:. 1633:: 1610:. 1590:: 1566:. 1536:. 1524:: 1500:. 1486:: 1459:. 1437:: 1410:. 1398:: 1375:. 1355:: 1332:. 1302:: 1275:. 1263:: 1236:. 1224:: 1199:. 1187:: 1160:. 1148:: 1124:. 1112:: 1085:. 1058:. 1046:: 980:. 976:: 953:. 926:. 912:: 882:. 870:: 847:. 825:: 795:. 781:: 751:. 739:: 716:. 689:. 679:5 662:. 650:: 627:. 615:: 532:. 518:. 306:. 291:. 236:a 232:n 228:h 224:e 222:( 20:)

Index

Phosphodiesterase inhibitors

drug
enzyme
phosphodiesterase
second messengers
cyclic adenosine monophosphate
cyclic guanosine monophosphate
Weiss
List of phosphodiesterase inhibitors
xanthines
caffeine
stimulant
aminophylline
IBMX
paraxanthine
pentoxifylline
theobromine
theophylline
bronchodilator
xanthines
phosphodiesterase inhibitors
cAMP
PKA
inhibit TNF-alpha
leukotriene
reduce inflammation
innate immunity
adenosine receptor
xanthine derivatives

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.